about
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelPodocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapyMetastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markersCirculating tumor cells in breast cancer: a tool whose time has come of ageHypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein responseA noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasisMechanisms of bone metastases of breast cancer2D protrusion but not motility predicts growth factor-induced cancer cell migration in 3D collagenUp-regulation of RhoGDI2 in human breast cancer and its prognostic implicationsGATA-3 links tumor differentiation and dissemination in a luminal breast cancer modelPhenotypic characterization of human colorectal cancer stem cellsAxin and GSK3- control Smad3 protein stability and modulate TGF- signalingTherapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.Stem-like features of cancer cells on their way to metastasisInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisIn Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right PlatformCancer Stem Cell Plasticity Drives Therapeutic ResistanceClaudin 1 in Breast Cancer: New InsightsThe double face of Morgana in tumorigenesisTargeting Breast Cancer MetastasisRecent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerCytochrome P450 ω-Hydroxylases in Inflammation and CancerMicroRNAs in breast cancer initiation and progressionCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasisThe emerging molecular machinery and therapeutic targets of metastasisCan molecular imaging enable personalized diagnostics? An example using magnetomotive photoacoustic imaging.Tumor cell migration in complex microenvironmentsCARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formationβ-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progressionCXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity.Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingGenetically engineered mouse models in oncology research and cancer medicineHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerHypoxia-inducible factor 1 and breast cancer metastasisCell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2.
P2860
Q21090788-220A6D14-17AE-467A-9326-8D04D8D952E3Q21146638-0572F240-61B6-4F98-93D4-262C1386C853Q21195203-AB171C48-1937-4269-93F6-F7EFF799E145Q21245253-DFB74464-B8A8-4741-8E08-599D88722E7CQ22000747-55F8A506-D66C-4E89-A617-5B4CFAA83D94Q24307454-98593AC6-5988-4349-AFD9-291B0CD3DAECQ24597798-56FC4CCA-8301-4E02-BAC4-855310C4F377Q24604968-4C3631BA-8508-40EB-8D24-37FB1BFDFEF0Q24632730-0064FF60-2E52-4996-AD81-A3B4E50657ABQ24657350-9EEE2654-BFFE-48EB-8243-39BA97183B0DQ24674126-A8500F2C-9EC3-4673-BD92-E39403553925Q24685123-BA708B60-33FE-4718-99BC-531087F04D7CQ25257819-63C0F6E8-60A7-402F-AF50-25DD7FB67CBFQ26741641-F78F61BC-911E-468D-8D10-55DD35B0E56BQ26767150-89A1FFD9-88F7-4FD1-9773-C504E7A1724DQ26767210-7EAB7E40-381D-4ADA-8B0A-FA19A14EC7B9Q26770274-9F19F513-167D-4A98-8343-BA2B169ECB1BQ26774988-5DD0A40E-6E20-46F3-9B4E-617492E6521DQ26783788-E4496827-CDB8-4BF2-A517-EB90CDDFD9ABQ26783925-09DF4026-7D65-4EDC-AB55-30C5DCB51873Q26784324-4D02E813-25E4-4C87-9470-93870CC21F75Q26800210-E2DBDFF8-FFA9-4CC1-BBCF-771FA29C3F4DQ26823360-44A033A7-D2F5-4A45-94F0-D5F8784EB2F2Q26830028-42A0865B-D3BD-4C08-AE91-6AEE05A75F06Q26991480-B1CB2AF7-1A3A-46F0-A481-EE59E61CFD07Q27022207-F46F9D94-AA7C-496C-8C5C-EC415947D363Q27025491-8634A49C-6E00-46EC-86C5-4FF3BDBE7ACFQ27027489-AED62BD6-5BCB-481A-B1E7-250700B4F864Q27305215-74E2C4CA-5ACE-45C7-A619-F98A0CDC97DDQ27314982-828A51FF-0731-4089-B218-C2B8F3F93CD6Q27325140-C35D83AB-CB58-4E5F-8A0D-3FC5AB76BE92Q27330200-5FF50FF1-6D50-49BD-A9D0-9F95115AA6BAQ27332400-8B225120-AC10-4E1C-BA62-B8A3B30E5816Q27682260-A51D47A6-10F0-4A6C-A150-0CCBC830BA58Q28066285-777C9FF8-CF2D-4C63-BA33-F1FA7E67D604Q28072021-3A45A235-2B47-4BBF-A5E6-F823967459CDQ28079323-ED70A91B-380A-412D-A3BF-3F0B572FC119Q28085413-A2E5BCE2-884A-49E6-9C1C-607A176143B2Q28087393-4CF3ED2D-86B3-4A35-BD57-6AFCC19E99DBQ28116157-1139A93B-56C3-4D7C-B486-38511BBBCFC1
P2860
description
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: August 2005)
@en
wetenschappelijk artikel (gepubliceerd in 2005-08)
@nl
наукова стаття, опублікована в серпні 2005
@uk
مقالة علمية (نشرت في أغسطس 2005)
@ar
name
Breast cancer metastasis: markers and models
@ast
Breast cancer metastasis: markers and models
@en
type
label
Breast cancer metastasis: markers and models
@ast
Breast cancer metastasis: markers and models
@en
prefLabel
Breast cancer metastasis: markers and models
@ast
Breast cancer metastasis: markers and models
@en
P2093
P2860
P3181
P356
P1476
Breast cancer metastasis: markers and models
@en
P2093
Peterse JL
van 't Veer LJ
P2860
P2888
P304
P3181
P356
10.1038/NRC1670
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1033699583